These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia. Sirota P, Mosheva T, Shabtay H, Giladi N, Korczyn AD. Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405 [Abstract] [Full Text] [Related]